148 related articles for article (PubMed ID: 21173630)
1. Denosumab (Prolia): A new option in the treatment of osteoporosis.
Belavic JM
Nurse Pract; 2011 Jan; 36(1):11-2. PubMed ID: 21173630
[No Abstract] [Full Text] [Related]
2. Denosumab (prolia) for postmenopausal osteoporosis.
Med Lett Drugs Ther; 2010 Oct; 52(1349):81-2. PubMed ID: 21045756
[No Abstract] [Full Text] [Related]
3. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
Wensel TM; Iranikhah MM; Wilborn TW
Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
[TBL] [Abstract][Full Text] [Related]
4. [Denosumab--a new efficient osteoporosis therapy].
Rejnmark L; Vestergaard P; Mosekilde L
Ugeskr Laeger; 2011 Jan; 173(5):346-9. PubMed ID: 21276398
[TBL] [Abstract][Full Text] [Related]
5. Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD.
Lewiecki EM; Miller PD; McClung MR; Cohen SB; Bolognese MA; Liu Y; Wang A; Siddhanti S; Fitzpatrick LA;
J Bone Miner Res; 2007 Dec; 22(12):1832-41. PubMed ID: 17708711
[TBL] [Abstract][Full Text] [Related]
6. Denosumab, osteoporosis, and prevention of fractures.
Kiechl S; Willeit J; Schett G
N Engl J Med; 2009 Nov; 361(22):2188-9; author reply 2190-1. PubMed ID: 19940304
[No Abstract] [Full Text] [Related]
7. Denosumab (prolia) for treatment of postmenopausal osteoporosis.
Johnson GL
Am Fam Physician; 2012 Feb; 85(4):334-6. PubMed ID: 22335312
[No Abstract] [Full Text] [Related]
8. Denosumab in postmenopausal women with low bone mineral density.
Schwartzman J; Yazici Y
N Engl J Med; 2006 Jun; 354(22):2390-1; author reply 2390-1. PubMed ID: 16738280
[No Abstract] [Full Text] [Related]
9. Clinical use of denosumab for the treatment for postmenopausal osteoporosis.
Lewiecki EM
Curr Med Res Opin; 2010 Dec; 26(12):2807-12. PubMed ID: 21050058
[TBL] [Abstract][Full Text] [Related]
10. [Austrian guidance for the pharmacologic treatment of osteoporosis in postmenopausal women: Addendum 2010].
Dimai HP; Pietschmann P; Resch H; Preisinger E; Fahrleitner-Pammer A; Dobnig H; Klaushofer K;
Wien Med Wochenschr; 2010 Dec; 160(21-22):586-9. PubMed ID: 21170699
[TBL] [Abstract][Full Text] [Related]
11. [Denosumab for treatment of postmenopausal osteoporosis].
Syversen U; Halse JI; Geisler J; Eriksen EF
Tidsskr Nor Laegeforen; 2011 Oct; 131(19):1893-6. PubMed ID: 21984295
[TBL] [Abstract][Full Text] [Related]
12. Denosumab for postmenopausal osteoporosis?
Drug Ther Bull; 2012 Jan; 50(1):6-8. PubMed ID: 22241889
[TBL] [Abstract][Full Text] [Related]
13. Effects of denosumab on the geometry of the proximal femur in postmenopausal women in comparison with alendronate.
Beck TJ; Lewiecki EM; Miller PD; Felsenberg D; Liu Y; Ding B; Libanati C
J Clin Densitom; 2008; 11(3):351-9. PubMed ID: 18495508
[TBL] [Abstract][Full Text] [Related]
14. The role and efficacy of denosumab in the treatment of osteoporosis: an update.
Charopoulos I; Orme S; Giannoudis PV
Expert Opin Drug Saf; 2011 Mar; 10(2):205-17. PubMed ID: 21208140
[TBL] [Abstract][Full Text] [Related]
15. Drugs for postmenopausal osteoporosis.
Treat Guidel Med Lett; 2008 Oct; 6(74):67-74; quiz 75-6. PubMed ID: 18800025
[No Abstract] [Full Text] [Related]
16. Denosumab, osteoporosis, and prevention of fractures.
Blythe SL
N Engl J Med; 2009 Nov; 361(22):2189-90; author reply 2190-1. PubMed ID: 19950410
[No Abstract] [Full Text] [Related]
17. [Denosumab efficient against osteoporosis. A biological drug gives new possibilities to treat a public disease].
Törring O
Lakartidningen; 2010 Mar 3-9; 107(9):574-5. PubMed ID: 20387753
[No Abstract] [Full Text] [Related]
18. Denosumab is an option for treatment of osteoporosis.
Simonelli C
Am Fam Physician; 2012 Dec; 86(11):992; author reply 994. PubMed ID: 23198660
[No Abstract] [Full Text] [Related]
19. Denosumab, osteoporosis, and prevention of fractures.
Blackwood J
N Engl J Med; 2009 Nov; 361(22):2189; author reply 2190-1. PubMed ID: 19950411
[No Abstract] [Full Text] [Related]
20. [Denosumab. The first inhibitor of RANK-ligand for treatment of osteoporosis].
Bruhn C
Med Monatsschr Pharm; 2010 Oct; 33(10):370-5. PubMed ID: 21072910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
